Laval, Canada

Anne-Marie Gelinas



 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **The Innovative Journey of Anne-Marie Gelinas**

Introduction

Anne-Marie Gelinas, an esteemed inventor based in Laval, Canada, has made noteworthy contributions to the field of medicine through her ground-breaking research and patent inventions. Known for her significant work in understanding tuberculosis, Gelinas has successfully secured two patents that highlight her expertise and dedication to combating this global health challenge.

Latest Patents

Gelinas' latest patents include innovative developments related to modified antigens. The first patent, titled "Modified Antigens - Modified Rv3616c Proteins and Their Use as Medicaments, Particularly for the Prevention of Reactivation of Tuberculosis," focuses on novel proteins designed to aid in preventing the reactivation of tuberculosis. The second patent closely follows, under the title "Modified Tuberculosis Antigens - Modified Rv3616c Proteins and Their Use as Medicaments, Particularly for the Prevention of Reactivation of Tuberculosis." Both patents reflect her commitment to advancing therapeutic options in the fight against tuberculosis.

Career Highlights

Throughout her career, Anne-Marie Gelinas has been affiliated with prominent companies in the pharmaceutical sector. Notably, she has worked with GlaxoSmithKline Biologicals and Glaxo Group Limited, where she contributed to innovative research projects aimed at developing effective medicinal solutions. Her experience in these companies has uniquely positioned her to explore groundbreaking scientific advancements.

Collaborations

Gelinas has collaborated with various professionals in her field, notably with colleagues Normand Blais and James R. Brown. These collaborations have fostered an environment of innovation and shared knowledge, pushing the boundaries of what is possible in therapeutic research.

Conclusion

Anne-Marie Gelinas stands out as a notable inventor whose work is paving the way for improved treatments in tuberculosis prevention. With her valuable patents and impactful collaborations, Gelinas continues to inspire the future of medical innovation and research. Her dedication to her craft exemplifies the spirit of inventorship in the quest for better health solutions worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…